Baloxavir Marboxil
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 311 publications
Analytical Techniques for Baloxavir Marboxil: A Critical Review of Chromatographic, Mass Spectrometric, and Emerging Methods (2018-2025).
Journal: Critical reviews in analytical chemistry
Published: June 23, 2026
Efficacy and safety of baloxavir marboxil vs. oseltamivir in Chinese outpatients with influenza B: an IPTW-adjusted real-world cohort study.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 30, 2026
Antiviral activities of multiple antivirals against highly pathogenic avian influenza A H5N1 in vitro and in mice.
Journal: Emerging microbes & infections
Published: March 31, 2026
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2024.
Journal: Communicable diseases intelligence (2018)
Published: February 23, 2026
Baloxavir Acid-Induced Mitochondrial Toxicity and Cell Cycle Arrest Contribute to Its Adverse Effects.
Journal: International journal of molecular sciences
Published: February 10, 2026
Psychiatric Symptoms after H1N1 Influenza Treated with Baloxavir Marboxil in Two Patients with Hematologic Malignancies.
Journal: Mediterranean journal of hematology and infectious diseases
Published: February 05, 2026
Design, synthesis, and evaluation of polycyclic pyridone derivatives as potent influenza inhibitors.
Design, synthesis, and evaluation of polycyclic pyridone derivatives as potent influenza inhibitors.
Journal: Bioorganic chemistry
Published: February 05, 2026
Emergence of the novel PA-D27G mutation conferring reduced baloxavir susceptibility in influenza A viruses circulating in China, 2018-2025.
Journal: Emerging microbes & infections
Published: January 20, 2026
In silico evaluation of FDA-approved antivirals and corticosteroids against SARS-CoV-2.
Journal: Scientific reports
Published: January 16, 2026
Baloxavir susceptibility of seasonal influenza viruses during the first seven seasons of clinical use in Japan, 2017/18 to 2023/24.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: January 09, 2026
Evaluation of therapeutic efficacy of baloxavir marboxil against high pathogenicity avian influenza virus infection in duck model.
Journal: PloS one
Published: December 18, 2025
Niclosamide inhibits the replication of highly pathogenic avian influenza A (H5Nx) viruses and antiviral-resistant mutants.
Journal: Antiviral research
Published: December 10, 2025
Last Updated: 06/30/2026